| Joaquin Duato |
Joaquin Duato is currently the Chairman & Chief Executive Officer at Johnson & Johnson since 2023. He is also a Director at U.S.-Spain Council, Inc. Mr. Duato previously served as the Chairman of Pharmaceutical Research & Manufacturers of America from 2017 to 2018. He was an Independent Director at Hess Corp. from 2019 to 2022 and a Director at United States Fund for UNICEF from 2019 to 2021. Mr. Duato has also held positions as a Director at CEO Roundtable on Cancer, Inc., Managing Director at Janssen-Cilag SpA, President at Ortho Biotech Products LP, and Trustee at Save The Children Federation Inc. He holds a graduate degree from Thunderbird School of Global Management and an MBA from Escuela Superior de Administración y Dirección de Empresas. |
| Joseph J. Wolk |
Joseph J. Wolk is currently the Director at Kenvue, Inc. and the Chief Financial Officer & Executive Vice President at Johnson & Johnson. He is also a Trustee at St. Joseph's University, a Member at Stanford University School of Medicine, a Member of the CNBC Global CFO Council, and a Member of the Wall Street Journal CFO Network. Previously, he served as the Chief Financial Officer & Vice President-Finance at Janssen Pharmaceuticals, Inc. from 2014 to 2016. Mr. Wolk has an undergraduate degree from St. Joseph's University and a graduate degree from Temple University Beasley School of Law. |
| William N. Hait |
William N. Hait is currently the Chief External Innovation & Executive VP-Medical at Johnson & Johnson since 2022. He is also the Executive Vice President at Johnson & Johnson Innovation - JJDC, Inc. since 2018. Additionally, he serves as the Treasurer for the American Association For Cancer Research Foundation and the American Association for Cancer Research. Formerly, Dr. Hait held positions as the Director at Vanderbilt University, the National Academy of Medicine (United States), Research!America, and the Yale Cancer Center. He was also the Director at Rutgers Cancer Institute of New Jersey and a Professor at the University of Medicine & Dentistry of New Jersey. Furthermore, he served as the Associate Dean at Robert Wood Johnson Medical School. He was the Global Head at Janssen Research & Development LLC from 2011 to 2018 and the Global Head-Research & Development at Janssen Global Services LLC from 2007 to 2017. Prior to that, he was the Chief-Medical Oncology Division at Yale School of Medicine. Dr. Hait completed his undergraduate studies at the University of Pennsylvania and obtained his doctorate degree from Drexel University College of Medicine. |
| James D. Swanson |
James D. Swanson is currently the Chief Information Officer & Executive VP at Johnson & Johnson. Prior to his current position, he served as the Director & Chief Information Officer at Monsanto Co. from 2013 to 2018 and as the Vice President-Information Technology at Merck & Co., Inc. from 2005 to 2013. He also held the position of Chief Information Officer at Bayer CropScience, Inc. Mr. Swanson obtained his undergraduate and graduate degrees from Drexel University. |
| Kathryn E. Wengel |
Kathryn E. Wengel is currently serving as the Vice Chairman at the National Association of Manufacturers and as the Chairman-Management Board at GS1 AISBL. She is also an Independent Director at Laboratory Corp. of America Holdings and a Member at Associazione Nazionale Produttori Illuminazione. In addition, Ms. Wengel has a background in undergraduate studies from Princeton University. |
| Robert J. Decker |
Robert J. Decker is currently the Chief Accounting Officer & Controller at Johnson & Johnson since 2019. He completed his undergraduate degree from Rider University. |
| Paul Ruh |
Paul Ruh is currently the Chief Financial Officer-Consumer Health at Johnson & Johnson and also holds the position of Chief Financial Officer at Kenvue, Inc. Prior to his current positions, he worked as the Chief Financial Officer-Latin America Division at PepsiCo, Inc. from 2015 to 2017. Mr. Ruh has an undergraduate degree from Universidad Iberoamericana and an MBA from MIT Sloan School of Management. |
| Ahmet Tezel |
Ahmet Tezel has a current job as the Global Head of Research & Development at Johnson & Johnson. |
| Peter M. Fasolo |
Peter M. Fasolo is currently a Director at Tufts University, HR Policy Association, Families & Work Institute,. Arm-In-Arm, Inc. (Maryland), Arm In Arm, Inc. (New Jersey), Kenvue, Inc., and a Trustee at Save The Children Federation Inc. He previously served as the Chief Human Resources Officer & Executive VP at Johnson & Johnson. Before that, he held positions as an Independent Director at HireRight Holdings Corp., Vice President-Worldwide Human Resources at Cordis Corp., Chief Talent Officer & VP-Global Talent Management at Johnson & Johnson, and Chief Talent Officer at Kohlberg Kravis Roberts & Co. LP. He also served as a Trustee at Robert Wood Johnson University Hospital, Inc. Dr. Fasolo holds a graduate degree from Fairleigh Dickinson University, an undergraduate degree from Providence College, and a doctorate degree from the University of Delaware. |
| Frederic H. Moll |
Frederic H. Moll is the founder of several companies. He founded EndoTherapeutics in 1992, Origin Medsystems, Inc. in 1989, INSPIRATION Medical GmbH in 2000, Intuitive Surgical, Inc. in 1995, Hansen Medical, Inc. in 2002, Restoration Robotics, Inc. in 2002, and Auris Health, Inc. in 2011. Currently, Dr. Moll holds several positions. He is the Chairman of PROCEPT BioRobotics Corp. since 2011, Chairman of Cephea Valve Technologies, Inc., Chairman of Neptune Medical, Inc. since 2023, Chairman of Moon Surgical SAS since 2023, Director of Tibion Corp., Director of Insightec Ltd. since 2020, Director of Neocis, Inc. since 2018, Director of G.I. Windows, Inc., Director of Focused Ultrasound Foundation, Director of Reflexion Medical, Inc. since 2016, Independent Director of Shockwave Medical, Inc. since 2011, Director of MIVI Neuroscience, Inc., Director of Avail Medsystems, Inc., Director of Accuryn Medical, Independent Director of Lux Health Tech Acquisition Corp. since 2020, and Chief Development Officer of Johnson & Johnson since 2019. He is also the Managing Partner of Sonder Capital Management LLC. Dr. Moll has held former positions as well. He was the Medical Director-Surgical Device Division at Guidant Corp. from 1992 to 1995, Independent Director at BIOLASE, Inc. from 2013 to 2017, Independent Director at MAKO Surgical Corp. from 2007 to 2013, Director at Aptus Endosystems, Inc., Director at Innovative Spinal Technologies, Inc., Independent Director at Intersect ENT, Inc. from 2006 to 2021, Director at Qool Therapeutics, Inc., Director at Venus Concept, Inc., and Advisor at Catalyst Health Ventures. Dr. Moll's education includes a graduate degree from Stanford University, an undergraduate degree from the University of California, Berkeley, and a doctorate degree from Washington University School of Medicine. |
| Paula A. Johnson |
Paula A. Johnson is currently an Independent Director at Johnson & Johnson, Director at The Isabella Stewart Gardner Museum, Inc., Director at Isabella Stewart Gardner Museum, President at Wellesley College, Trustee at The Rockefeller University, Member of the American Academy of Arts & Sciences, and Member of the National Academy of Medicine (United States). Previously, she served as an Independent Director at ABIOMED, Inc., Eaton Vance Corp., and West Pharmaceutical Services, Inc. She was also the Executive Director-Connors Center at The Brigham & Women's Hospital, Inc. In addition, she held positions as an Associate Professor at Harvard Medical School and a Professor at Harvard T.H. Chan School of Public Health. Dr. Johnson obtained a doctorate degree from Harvard Medical School, an undergraduate degree from Radcliffe College, and a graduate degree from Harvard T.H. |
| Darius Adamczyk |
Darius Adamczyk is currently the Chief Executive Officer at Honeywell International, Inc. (Minnesota). He is also the Executive Chairman at Honeywell International, Inc., the Chairman at Quantinuum Ltd., and an Independent Director at Johnson & Johnson. Additionally, he is a Member of the Council on Foreign Relations, Inc., The Business Roundtable, The Business Council, the US-China Business Council, and the Aspen Economic Strategy Group. In the past, Mr. Adamczyk served as the Chief Executive Officer & Director at Metrologic Instruments, Inc., the President & Chief Executive Officer at Honeywell Process Solutions, and a Director at Garrett Motion, Inc. He also worked as an Electrical Engineer at GE Aerospace and a Senior Associate at Booz Allen Hamilton, Inc. Furthermore, he was the President at Honeywell Scanning & Mobility. Mr. Adamczyk completed his undergraduate degree at Michigan State University in 1988. He obtained an MBA from Harvard University in 1995. He also holds a graduate degree from Syracuse University, which he received in 1991. |
| D. Scott Davis |
D. Scott Davis is currently an Independent Director at Johnson & Johnson since 2014 and the Lead Independent Director at Honeywell International, Inc. since 2005. He is also a Trustee at The Annie E. Casey Foundation, Inc. and a Member at The Business Roundtable. In the past, Mr. Davis served as the Chief Executive Officer at Overseas Partners Ltd. from 1998 to 2000. He was also the Chief Executive Officer at UPS Aviation Technologies, Inc. and Liquid Advertising Corp. Additionally, he held the position of Non-Executive Chairman at United Parcel Service, Inc. and UPS Consulting, Inc. from 2000 to 2016. He was the Chairman of the Georgia Council on Economic Education. Furthermore, he served as a Director at EndoChoice, Inc. from 2014 to 2016 and as an Independent Director at EndoChoice Holdings, Inc. from 2013 to 2016. He was a Director at the Federal Reserve Bank of Atlanta from 2003 to 2009 and a Member of The Carter Center, Inc. and the President's Export Council. Mr. Davis obtained his undergraduate degree from Portland State University. |
| Jennifer A. Doudna |
Jennifer A. Doudna is the founder of Caribou Biosciences, Inc. (2011), Editas Medicine, Inc. (2013), Intellia Therapeutics, Inc. (2014), and Innovative Genomics Institute (2014). She is also the founder of Mammoth Biosciences, Inc., Scribe Therapeutics, Inc., and others. Currently, Dr. Doudna holds positions as an Independent Director at Johnson & Johnson, Director at Tempus Labs, Inc., Director at Driver, Inc., Director at Altos Labs, Inc., Trustee at Pomona College, Professor at the University of California, Berkeley, and Member-Molecular, Cell Biology & Chemistry at Lawrence Berkeley National Laboratory, National Academy of Sciences, and American Academy of Arts & Sciences. She is also a Chancellor Chair at Li Ka Shing (Canada) Foundation, iPartner at The Column Group LLC, Chief Science Advisor at TPG Sixth Street Partners LLC, and a member of the Scientific Advisory Board at eFFECTOR Therapeutics, Inc. Dr. Doudna's former positions include Vice President-Discovery Research at Genentech, Inc., Consultant at Pfizer Inc. and Merck Ltd., Member at The Royal Society, and Advisor at Orchard Venture Partners. Dr. Doudna received her undergraduate degree from Pomona College and her doctorate from Harvard University. |
| Marillyn A. Hewson |
Marillyn A. Hewson currently works at The Business Roundtable, as Vice Chairman, The Kennedy Center Corporate Fund, as Vice Chairman, Chevron Corp., as Independent Director from 2021, and various other companies. Ms. Hewson also formerly worked at Lockheed Martin Ventures, as Chairman, President & CEO from 2014 to 2020, Lockheed Martin Corp., as Executive Chairman from 2020 to 2021, Lockheed Martin Investment Management Co., as Executive Chairman from 2020 to 2022, and various other companies. Ms. Hewson received her undergraduate degree in 1976 from The University of Alabama and graduate degree in 1979 from The University of Alabama. |
| Eugene A. Woods |
Eugene A. Woods is currently serving as the President & Chief Executive Officer at The Charlotte-Mecklenburg Hospital Authority (North Carolina), Carolinas College of Health Sciences, Atrium Health, Inc., Advocate Health, Inc., and Advocate Aurora Health, Inc. He is also an Independent Director at Best Buy Co., Inc. and Johnson & Johnson. In the past, Mr. Woods held positions such as Chief Executive Officer & SVP-Operations at St. Joseph Health System, President & Chief Executive Officer at Roy Lester Schneider Hospital, Chairman at American Hospital Association, Inc., Vice President-Administration at Bon Secours Mercy Health Petersburg LLC, President & Chief Operating Officer at CHRISTUS Health, Inc., and Chief Operating Officer & Senior Vice President at Washington Hospital Center Corp. Mr. Woods has a background in healthcare administration and holds undergraduate and graduate degrees from The Pennsylvania State University, as well as an MBA. |
| Mark Alan Weinberger |
Mark Alan Weinberger is the founder of Washington Counsel PC, which was founded in 1996. He held the title of Principal from 1996 to 2000. Mr. Weinberger's current jobs include being an Independent Director at Johnson & Johnson, MetLife, Inc., JPMorgan Chase & Co., and Saudi Arabian Oil Co. He is also a Director at the National Bureau of Economic Research, Inc., The Tax Council, and The Bullis School, Inc. Additionally, Mr. Weinberger is a Director at Ernst & Young (Nigeria), MetLife Services & Solutions LLC, and a Trustee at Emory University, Case Western Reserve University, United States Council for International Business, The Concord Coalition, and The American Council for Capital Formation. He is a Member of the Aspen Economic Strategy Group and a Trustee at the Greater Washington Partnership. Mr. Weinberger's former jobs include being the Chairman & Chief Executive Officer at Ernst & Young LLP from 2013 to 2019. He was also a Vice Chairman at The Kennedy Center Corporate Fund and a Director at Catalyst, Inc. and The Business Roundtable. Mr. Weinberger served as an Independent Director at Accelerate Acquisition Corp. from 2021 to 2022. He was an Assistant Secretary at the U.S. Department of the Treasury from 2001 to 2002. Mr. Weinberger was a Partner at Oldaker Law Group LLP and Ryan Phillips Utrecht & Mackinnon from 1995 to 1996. In terms of education, Mr. Weinberger received his undergraduate degree from Emory University in 1983. He obtained his graduate degree and MBA from Case Western Reserve University in 1987 and 1986 respectively. He also holds a graduate degree from Georgetown University Law Center, which he received in 1991. |
| Nadja Y. West |
Nadja Y. West is an Independent Director for Johnson & Johnson, Nucor Corp., and Tenet Healthcare Corp. He is also a Director for AmeriCares Foundation, Inc., Woodruff Foundation, Tempus Labs, Inc., and a Trustee for Mount St. Mary's University, Inc. and National Recreation Foundation. West is a former Commanding General for the U.S. Army Medical Department and a former Deputy Chief of Staff for the same department. He received his undergraduate degree from the US Military Academy, his graduate degree from National Defense University, and his doctorate from George Washington University School of Medicine & Health. |
| Hubert Joly |
Hubert Joly currently works at Minnesota Business Partnership, Inc., as Vice Chairman, The Business Council, as Vice Chairman, Johnson & Johnson, as Independent Director from 2019, Ralph Lauren Corp., as Lead Independent Director from 2021, Sciences Po American Foundation, as Director, The New York Public Library Astor Lenox & Tilden Foundations, as Trustee, Minnesota Orchestral Association, as Trustee, and The Minneapolis Society of Fine Arts, as Trustee. Mr. Joly also formerly worked at Vivendi SE, as Chief Executive Officer-Video Game Unit, Carlson, Inc., as President, Chief Executive Officer & Director from 2008 to 2012, Carlson Wagonlit Travel, Inc., as Chairman, President & Chief Executive Officer from 2004 to 2008, Radisson Hospitality LLC, as President & Chief Executive Officer, Park Inn Hotels, as President, Chief Executive Officer & Director, CW Travel Holdings NV, as President, Chief Executive Officer & Director, Best Buy Co., Inc., as Executive Chairman from 2019 to 2020, Radisson Hospitality AB, as Vice Chairman in 2012, Retail Industry Leaders Association, as Vice Chairman, World Travel & Tourism Council Ltd., as Director, Electronic Data Systems Corp., as Vice President-European Region, McKinsey & Co., Inc., as Partner, Vivendi Universal Games, Inc., as Executive VP-American Assets & Deputy CFO from 2002 to 2004, and Electronic Data Systems France SAS, as President & Vice President-Europe from 1996 to 1999. Mr. Joly received his undergraduate degree from Sciences Po and undergraduate degree from École des Hautes Études Commerciales de Paris. |
| Mary C. Beckerle |
Mary C. Beckerle is currently the Chief Executive Officer-Huntsman Cancer Institute at the University of Utah Health Care and the Chief Executive Officer at Huntsman Cancer Institute. She is also an Independent Director at Johnson & Johnson, a Director at Huntsman International LLC, a Director at Exelixis, Inc., and an Independent Director at Huntsman Corp. Additionally, she serves as a Director at Coalition For Life Sciences and a Member-Cancer Policy at the University of Pennsylvania. Dr. Beckerle is a Professor at the University of Utah and a Member of the National Academy of Sciences, the American Philosophical Society, the Duke University School of Medicine, the Georgetown University Medical Center, the National Center For Biological Sciences, and the American Academy of Arts & Sciences. She has previously held positions as the Chief Executive Officer at the National Cancer Institute, the Chairman-Council for Extramural Grants at the American Cancer Society, Inc., the Director at the Howard Hughes Medical Institute, Inc., and the Director at the National Institutes of Health. She has also served as the Director of the Huntsman Cancer Foundation, the Director of the American Association for Cancer Research, and the President of The American Society for Cell Biology. Dr. Beckerle holds a doctorate degree from The University of Colorado and an undergraduate degree from Wells College. |
| Mark B. McClellan |
Mark B. McClellan is Senior Advisor & Advisory Board Member at Arsenal Capital Management LP, Operating Partner at CR Group LP and Director & Managing Director at Alignment Healthcare USA LLC. Dr. McClellan is also Professor at Duke University, Administrator at US Department of Health & Human Services (DC), Member of National Academy of Medicine (United States) and Member of Dell Medical School and on the board of 15 other companies.
In the past Dr. McClellan was Advisor at InterWest Partners LLC, Senior Director-Healthcare Policy at The White House, Administrator at Centers for Medicare & Medicaid Services (US), Deputy Assistant Secretary-Economic Policy at US Department of The Treasury, Commissioner at US Food & Drug Administration, Member of Council of Economic Advisers, Associate Professor at Stanford University and Director-Healthcare Innovation & Value Initiative at The Brookings Institution.
Mark B. McClellan received a doctorate from Massachusetts Institute of Technology, an undergraduate degree from The University of Texas at Austin, a doctorate from Harvard Mit Health Sciences & Technology and a graduate degree from Harvard Kennedy School of Government. |
